Cameron Turtle
Director; Director, Chief Executive Officer · 10 filings · Latest: Oct 1, 2026
Damora Therapeutics, Inc.
Spyre Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SYRE | Cameron Turtle | Director, Chief Executive Officer | Oct 1, 2026 | Sale | $92.01 | 15,000 | $1.4M | 537,540 | |
SYRE | CAMERON TURTLE | — | Oct 1, 2026 | Proposed Sale | $89.03 | 45,000 | $4.0M | — | |
SYRE | Cameron Turtle | Director, Chief Executive Officer | Sep 1, 2026 | Sale | $87.29 | 15,000 | $1.3M | 552,540 | |
SYRE | Cameron Turtle | Director, Chief Executive Officer | Aug 3, 2026 | Sale | $95.51 | 15,000 | $1.4M | 567,540 | |
SYRE | Cameron Turtle | Director, Chief Executive Officer | Jul 1, 2026 | Sale | $87.69 | 15,000 | $1.3M | 582,540 | |
SYRE | CAMERON TURTLE | — | Jul 1, 2026 | Proposed Sale | $88.78 | 45,000 | $4.0M | — | |
SYRE | Cameron Turtle | Director, Chief Executive Officer | Jun 1, 2026 | Sale | $70.43 | 15,000 | $1.1M | 597,540 | |
SYRE | Cameron Turtle | Director, Chief Executive Officer | May 1, 2026 | Sale | $71.37 | 15,000 | $1.1M | 612,540 | |
SYRE | Cameron Turtle | Director, Chief Executive Officer | Apr 1, 2026 | Sale | $49.33 | 15,000 | $739.9K | 627,540 | |
SYRE | Cameron Turtle | Director, Chief Executive Officer | Mar 2, 2026 | Sale | $42.19 | 15,000 | $632.9K | 642,540 | |
SYRE | CAMERON TURTLE | — | Mar 2, 2026 | Proposed Sale | $43.01 | 60,000 | $2.6M | — | |
SYRE | Cameron Turtle | Director, Chief Executive Officer | Feb 2, 2026 | Sale | $32.80 | 15,000 | $492.0K | 657,540 | |
SYRE | CAMERON TURTLE | — | Nov 3, 2025 | Proposed Sale | $24.46 | 90,000 | $2.2M | — |